David M. Dobrzynski, M.D.

Locations

601 Elmwood Avenue, 3rd Floor
Rochester, NY 14620

About Me

Professional Background

Dr. Dobrzynski received his Bachelor of Science in Biochemistry from Bucknell University and his Doctorate of Medicine from Albany Medical College. He completed his Internal Medicine Residency at Wake Forest Baptist Medical Center(WFBMC) in Winston-Salem, NC. He continued on as faculty at WFBMC as a...

Dr. Dobrzynski received his Bachelor of Science in Biochemistry from Bucknell University and his Doctorate of Medicine from Albany Medical College. He completed his Internal Medicine Residency at Wake Forest Baptist Medical Center(WFBMC) in Winston-Salem, NC. He continued on as faculty at WFBMC as an Assistant Chief of Medicine for the following year. He then went on to complete his Infectious Diseases Fellowship at Vanderbilt University in Nashville, TN.
He currently sees inpatients on the General Infectious Diseases consult service as well as outpatients in the general ID Clinic. He also serves as Program Director of the Infectious Diseases Fellowship Program and Medical Director for the Antimicrobial Stewardship Program at Strong Memorial Hospital.

Certified Specialties

Infectious Disease - American Board of Internal Medicine

Internal Medicine - American Board of Internal Medicine

Faculty Appointments

Assistant Professor - Department of Medicine, Infectious Diseases (SMD)

Credentials

Residency & Fellowship

Fellowship, Infectious Disease, Vanderbilt University Medical Center. 2016 - 2018

Residency, Internal Medicine, Wake Forest University Baptist Medical Center-Radiology. 2013 - 2015

Internship, Internal Medicine, Wake Forest University Baptist Medical Center-Radiology. 2012 - 2013

Education

MD | Albany Medical College. 2012

Research

His main clinical research interests include respiratory viral infections, COVID-19 therapeutics, antimicrobial stewardship, multi-drug resistant organisms, and hospital-acquired infections. He also remains active in teaching of fellows, residents, and medical students.

Publications

Journal Articles

High-Volume, High-Acuity, and High-Impact Learning: Tips and Tricks for Infectious Diseases Training Programs.

Luther VP, Paras ML, Schultz S, Aziz M, Balba G, McCarty TP, Razonable RR, Reece R, Shnekendorf R, Sundareshan V, Chirch LM,

Open forum infectious diseases.. 2024 March 11 (3):ofae016. Epub 01/08/2024.

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants.

Lyke KE, Atmar RL, Dominguez Islas C, Posavad CM, Deming ME, Branche AR, Johnston C, El Sahly HM, Edupuganti S, Mulligan MJ, Jackson LA, Rupp RE, Rostad CA, Coler RN, Bäcker M, Kottkamp AC, Babu TM, Dobrzynski D, Martin JM, Brady RC, Frenck RW, Rajakumar K, Kotloff K, Rouphael N, Szydlo D, PaulChoudhury R, Archer JI, Crandon S, Ingersoll B, Eaton A, Brown ER, McElrath MJ, Neuzil KM, Stephens DS, Post DJ, Lin BC, Serebryannyy L, Beigel JH, Montefiori DC, Roberts PC,

NPJ vaccines.. 2023 July 118 (1):98. Epub 07/11/2023.

Epidemiology of Gram-Negative Bloodstream Infections in the United States: Results From a Cohort of 24 Hospitals.

Ince D, Fiawoo S, Choudhury R, Cosgrove SE, Dobrzynski D, Gold H, Lee JH, Percival KM, Shulder S, Sony D, Spivak ES, Tamma PD, Nori P

Open forum infectious diseases.. 2023 July 10 (7):ofad265. Epub 05/22/2023.

Clinical Outcomes and Treatment Strategies in Patients With Non-Carbapenemase-producing Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacterales Infections.

Debnath A, Pillinger KE, Martin AJ, Dobrzynski D, Cameron A, Shulder S

The Annals of pharmacotherapy.. 2022 October 21 :10600280221132019. Epub 10/21/2022.

Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant.

Lyke KE, Atmar RL, Islas CD, Posavad CM, Szydlo D, Paul Chourdhury R, Deming ME, Eaton A, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE, Mulligan MJ, Brady RC, Frenck RW, Bäcker M, Kottkamp AC, Babu TM, Rajakumar K, Edupuganti S, Dobrzynski D, Coler RN, Archer JI, Crandon S, Zemanek JA, Brown ER, Neuzil KM, Stephens DS, Post DJ, Nayak SU, Suthar MS, Roberts PC, Beigel JH, Montefiori DC,

Cell reports. Medicine.. 2022 June 20 :100679. Epub 06/20/2022.

Homologous and Heterologous Covid-19 Booster Vaccinations.

Atmar RL, Lyke KE, Deming ME, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE, Mulligan MJ, Brady RC, Frenck RW, Bäcker M, Kottkamp AC, Babu TM, Rajakumar K, Edupuganti S, Dobrzynski D, Coler RN, Posavad CM, Archer JI, Crandon S, Nayak SU, Szydlo D, Zemanek JA, Dominguez Islas CP, Brown ER, Suthar MS, McElrath MJ, McDermott AB, O'Connell SE, Montefiori DC, Eaton A, Neuzil KM, Stephens DS, Roberts PC, Beigel JH,

The New England journal of medicine.. 2022 January 26 Epub 01/26/2022.

Antibiotic Use and Associated Risk Factors for Antibiotic Prescribing in COVID-19 Hospitalized Patients.

Martin AJ, Shulder S, Dobrzynski D, Quartuccio K, Pillinger KE

Journal of pharmacy practice.. 2021 July 22 :8971900211030248. Epub 07/22/2021.

Hospital Readmissions After Laboratory-Confirmed Influenza Hospitalization.

Dobrzynski DM, Ndi DN, Zhu Y, Markus T, Schaffner W, Talbot HK

The Journal of infectious diseases.. 2020 July 23222 (4):583-589. Epub 1900 01 01.

Ratings & Reviews

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.